Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125943201 | 12594320 | 1 | I | 20160702 | 20160712 | 20160726 | 20160726 | EXP | US-PFIZER INC-2016342589 | PFIZER | 69.00 | YR | F | Y | 79.30000 | KG | 20160726 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125943201 | 12594320 | 1 | PS | PALBOCICLIB | PALBOCICLIB | 1 | Oral | 125 MG, DAILY ON DAYS 1-21 (EVERY 28 DAYS) | U | 207103 | 125 | MG | |||||||
| 125943201 | 12594320 | 2 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | U | 18667 | ||||||||||
| 125943201 | 12594320 | 3 | SS | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125943201 | 12594320 | 4 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | UNK | 0 | |||||||||||
| 125943201 | 12594320 | 5 | C | calcium carbonate-vit D3 | 2 | UNK | 0 | ||||||||||||
| 125943201 | 12594320 | 6 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | UNK | 0 | |||||||||||
| 125943201 | 12594320 | 7 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | UNK | 0 | |||||||||||
| 125943201 | 12594320 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | 0 | |||||||||||
| 125943201 | 12594320 | 9 | C | LOVASTATIN. | LOVASTATIN | 1 | UNK | 0 | |||||||||||
| 125943201 | 12594320 | 10 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | UNK | 0 | |||||||||||
| 125943201 | 12594320 | 11 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | Sublingual | UNK | 0 | ||||||||||
| 125943201 | 12594320 | 12 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 125943201 | 12594320 | 13 | C | SENNOSIDES. | SENNOSIDES | 1 | UNK | 0 | |||||||||||
| 125943201 | 12594320 | 14 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | UNK | 0 | |||||||||||
| 125943201 | 12594320 | 15 | C | TRIAMCINOLONE ACETONIDE. | TRIAMCINOLONE ACETONIDE | 1 | Nasal | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125943201 | 12594320 | 1 | Squamous cell carcinoma of lung |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125943201 | 12594320 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125943201 | 12594320 | Asthenia | |
| 125943201 | 12594320 | Fatigue | |
| 125943201 | 12594320 | Hepatic enzyme increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125943201 | 12594320 | 1 | 20160610 | 20160630 | 0 |